News | May 10, 2022
Sun gets 10 observations from USFDA for Halol facility
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
Subscribe To Our Newsletter & Stay Updated
